<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The rate of collagen synthesis in the cell layer fraction of the skin fibroblasts derived from a patient with <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> was greater than that in the <z:mpath ids='MPATH_458'>normal</z:mpath> fibroblasts </plain></SENT>
<SENT sid="1" pm="."><plain>Neither the relative content of type III collagen nor the level of <z:chebi fb="0" ids="26274,32874">prolyl</z:chebi> and <z:chebi fb="0" ids="32568">lysyl</z:chebi> hydroxylations in type I collagen changed </plain></SENT>
<SENT sid="2" pm="."><plain>Intracellular degradation rate of collagen in <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> fibroblasts was decreased to one fifth of that in the <z:mpath ids='MPATH_458'>normal</z:mpath> fibroblasts </plain></SENT>
<SENT sid="3" pm="."><plain>These results suggest that abnormal collagen metabolism may be related to the pathogenesis of clinical manifestations of <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> </plain></SENT>
</text></document>